- Home
- AVNW vs ALDX Comparison
AVNW vs ALDX Comparison
Compare AVNW & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- ALDX
- Stock Information
- Founded
- AVNW 2006
- ALDX 2004
- Country
- AVNW United States
- ALDX United States
- Employees
- AVNW N/A
- ALDX N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- AVNW Technology
- ALDX Health Care
- Exchange
- AVNW Nasdaq
- ALDX Nasdaq
- Market Cap
- AVNW 274.4M
- ALDX 313.4M
- IPO Year
- AVNW 2007
- ALDX 2014
- Fundamental
- Price
- AVNW $22.01
- ALDX $5.60
- Analyst Decision
- AVNW Strong Buy
- ALDX Strong Buy
- Analyst Count
- AVNW 4
- ALDX 2
- Target Price
- AVNW $36.50
- ALDX $9.50
- AVG Volume (30 Days)
- AVNW 113.2K
- ALDX 715.8K
- Earning Date
- AVNW 11-04-2025
- ALDX 11-06-2025
- Dividend Yield
- AVNW N/A
- ALDX N/A
- EPS Growth
- AVNW N/A
- ALDX N/A
- EPS
- AVNW 0.10
- ALDX N/A
- Revenue
- AVNW $434,606,000.00
- ALDX N/A
- Revenue This Year
- AVNW $6.43
- ALDX N/A
- Revenue Next Year
- AVNW $7.33
- ALDX $36.23
- P/E Ratio
- AVNW $220.00
- ALDX N/A
- Revenue Growth
- AVNW 6.50
- ALDX N/A
- 52 Week Low
- AVNW $12.96
- ALDX $1.14
- 52 Week High
- AVNW $26.83
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- AVNW 41.69
- ALDX 59.73
- Support Level
- AVNW $22.20
- ALDX $5.13
- Resistance Level
- AVNW $23.13
- ALDX $5.78
- Average True Range (ATR)
- AVNW 0.70
- ALDX 0.23
- MACD
- AVNW -0.15
- ALDX 0.06
- Stochastic Oscillator
- AVNW 3.04
- ALDX 84.00
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.